The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn's Disease.
Kosinsky RL, Gonzalez MM, Saul D, Barros LL, Sagstetter MR, Fedyshyn Y, Nair A, Sun Z, Hamdan FH, Gibbons HR, Perez Pachon ME, Druliner BR, Johnsen SA, Faubion WA.
Kosinsky RL, et al. Among authors: johnsen sa.
Gastroenterology. 2024 Apr;166(4):631-644.e17. doi: 10.1053/j.gastro.2024.01.007. Epub 2024 Jan 9.
Gastroenterology. 2024.
PMID: 38211712